Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
10 2020
Historique:
received: 06 09 2018
accepted: 02 07 2020
pubmed: 2 10 2020
medline: 15 12 2020
entrez: 1 10 2020
Statut: ppublish

Résumé

Blood vessels support tumours by providing nutrients and oxygen, while also acting as conduits for the dissemination of cancer

Identifiants

pubmed: 32999457
doi: 10.1038/s41586-020-2774-y
pii: 10.1038/s41586-020-2774-y
pmc: PMC8088828
mid: NIHMS1691936
doi:

Substances chimiques

Intercellular Signaling Peptides and Proteins 0
Nerve Tissue Proteins 0
RNA, Double-Stranded 0
Receptors, Immunologic 0
Toll-Like Receptor 3 0
Slit homolog 2 protein R6FXH13RRC

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-304

Subventions

Organisme : NIGMS NIH HHS
ID : R01 GM123977
Pays : United States
Organisme : NIH HHS
ID : R01CA24098
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA240984
Pays : United States
Organisme : NIH HHS
ID : R01-CA236954-01A1
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA236954
Pays : United States

Références

Strilic, B. et al. Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis. Nature 536, 215–218 (2016).
pubmed: 27487218
Png, K. J., Halberg, N., Yoshida, M. & Tavazoie, S. F. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481, 190–194 (2012).
Pencheva, N. et al. Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis. Cell 151, 1068–1082 (2012).
pubmed: 23142051 pmcid: 3753115
Pencheva, N. & Tavazoie, S. F. Control of metastatic progression by microRNA regulatory networks. Nat. Cell Biol. 15, 546–554 (2013).
pubmed: 23728460 pmcid: 4678324
Rafii, S., Butler, J. M. & Ding, B. S. Angiocrine functions of organ-specific endothelial cells. Nature 529, 316–325 (2016).
pubmed: 26791722 pmcid: 4878406
Kobayashi, H. et al. Angiocrine factors from Akt-activated endothelial cells balance self-renewal and differentiation of haematopoietic stem cells. Nat. Cell Biol. 12, 1046–1056 (2010).
pubmed: 20972423 pmcid: 2972406
Ding, B. S. et al. Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell 147, 539–553 (2011).
pubmed: 22036563 pmcid: 3228268
Ding, B. S. et al. Inductive angiocrine signals from sinusoidal endothelium are required for liver regeneration. Nature 468, 310–315 (2010).
pubmed: 21068842 pmcid: 3058628
Tavora, B. et al. Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy. Nature 514, 112–116 (2014).
pubmed: 25079333 pmcid: 4533916
Sanz, E. et al. Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc. Natl Acad. Sci. USA 106, 13939–13944 (2009).
pubmed: 19666516 pmcid: 2728999
Wang, Y. et al. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis. Nature 465, 483–486 (2010).
pubmed: 20445537
Gibson, D. A. et al. Dendrite self-avoidance requires cell-autonomous Slit/Robo signaling in cerebellar purkinje cells. Neuron 81, 1040–1056 (2014).
pubmed: 24607227 pmcid: 3963503
Brose, K. et al. Slit proteins bind Robo receptors and have an evolutionarily conserved role in repulsive axon guidance. Cell 96, 795–806 (1999).
pubmed: 10102268
Wang, K. H. et al. Biochemical purification of a mammalian Slit protein as a positive regulator of sensory axon elongation and branching. Cell 96, 771–784 (1999).
pubmed: 10102266
Strickland, P., Shin, G. C., Plump, A., Tessier-Lavigne, M. & Hinck, L. Slit2 and netrin 1 act synergistically as adhesive cues to generate tubular bi-layers during ductal morphogenesis. Development 133, 823–832 (2006).
pubmed: 16439476
Svensson, K. J. et al. A secreted Slit2 fragment regulates adipose tissue thermogenesis and metabolic function. Cell Metab. 23, 454–466 (2016).
pubmed: 26876562 pmcid: 4785066
Ballard, M. S. & Hinck, L. A roundabout way to cancer. Adv. Cancer Res. 114, 187–235 (2012).
pubmed: 22588058 pmcid: 4121377
Lang, J. E. et al. RNA-seq of circulating tumor cells in stage II–III breast cancer. Ann. Surg. Oncol. 25, 2261–2270 (2018).
pubmed: 29868978 pmcid: 7065419
Gantier, M. P. & Williams, B. R. The response of mammalian cells to double-stranded RNA. Cytokine Growth Factor Rev. 18, 363–371 (2007).
pubmed: 17698400 pmcid: 2084215
Johnsen, I. B. et al. Toll-like receptor 3 associates with c-Src tyrosine kinase on endosomes to initiate antiviral signaling. EMBO J. 25, 3335–3346 (2006).
pubmed: 16858407 pmcid: 1523188
Itoh, K., Watanabe, A., Funami, K., Seya, T. & Matsumoto, M. The clathrin-mediated endocytic pathway participates in dsRNA-induced IFN-β production. J. Immunol. 181, 5522–5529 (2008).
pubmed: 18832709
Kawasaki, T. & Kawai, T. Toll-like receptor signaling pathways. Front. Immunol. 5, 461 (2014).
pubmed: 25309543 pmcid: 4174766
Shivapurkar, N. et al. Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res. 59, 3576–3580 (1999).
pubmed: 10446964
Dallol, A. et al. Frequent epigenetic inactivation of the SLIT2 gene in gliomas. Oncogene 22, 4611–4616 (2003).
pubmed: 12881718
Gröne, J. et al. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol. Rep. 15, 1437–1443 (2006).
pubmed: 16685377
Huang, W. Y. et al. MethHC: a database of DNA methylation and gene expression in human cancer. Nucleic Acids Res. 43, D856–D861 (2015).
pubmed: 25398901
Macias, H. et al. SLIT/ROBO1 signaling suppresses mammary branching morphogenesis by limiting basal cell number. Dev. Cell 20, 827–840 (2011).
pubmed: 21664580 pmcid: 3129866
Macias, H. & Hinck, L. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 1, 533–557 (2012).
pubmed: 22844349 pmcid: 3404495
Marlow, R. et al. SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res. 68, 7819–7827 (2008).
pubmed: 18829537 pmcid: 3075571
Escamilla-Tilch, M. et al. The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer? Immunol. Cell Biol. 91, 601–610 (2013).
pubmed: 24100386
Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467–472 (2018).
pubmed: 29342134 pmcid: 5785464
Nabet, B. Y. et al. Exosome RNA unshielding couples stromal activation to pattern recognition receptor signaling in cancer. Cell 170, 352–366 (2017).
pubmed: 28709002 pmcid: 6611169
Redzic, J. S., Balaj, L., van der Vos, K. E. & Breakefield, X. O. Extracellular RNA mediates and marks cancer progression. Semin. Cancer Biol. 28, 14–23 (2014).
pubmed: 24783980
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G. & Hacohen, N. Molecular and genetic properties of tumors associated with local immune cytolytic activity. Cell 160, 48–61 (2015).
pubmed: 25594174 pmcid: 4856474
Kassiotis, G. Endogenous retroviruses and the development of cancer. J. Immunol. 192, 1343–1349 (2014).
pubmed: 24511094
Zernecke, A. & Preissner, K. T. Extracellular ribonucleic acids (RNA) enter the stage in cardiovascular disease. Circ. Res. 118, 469–479 (2016).
pubmed: 26846641
Khakpour, S., Wilhelmsen, K. & Hellman, J. Vascular endothelial cell Toll-like receptor pathways in sepsis. Innate Immun. 21, 827–846 (2015).
pubmed: 26403174
Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436–444 (2008).
pubmed: 18650914
Tavazoie, S. F. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 451, 147–152 (2008).
pubmed: 18185580 pmcid: 2782491
Reynolds, L. E. & Hodivala-Dilke, K. M. Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol. Med. 120, 503–509 (2006).
pubmed: 16491622
Aslakson, C. J. & Miller, F. R. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 52, 1399–1405 (1992).
pubmed: 1540948
Fidler, I. J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218–224 (1975).
pubmed: 1109790
May, T. et al. Establishment of murine cell lines by constitutive and conditional immortalization. J. Biotechnol. 120, 99–110 (2005).
pubmed: 16026879
Guy, C. T., Cardiff, R. D. & Muller, W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12, 954–961 (1992).
pubmed: 1312220 pmcid: 369527
Wagner, K. U. et al. Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res. 25, 4323–4330 (1997).
pubmed: 9336464 pmcid: 147032
Lánczky, A. et al. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res. Treat. 160, 439–446 (2016).
pubmed: 27744485
DeRose, Y. S. et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat. Med. 17, 1514–1520 (2011).
pubmed: 22019887 pmcid: 3553601
Sikora, M. J. et al. Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen response. Cancer Res. 74, 1463–1474 (2014).
pubmed: 24425047 pmcid: 3955299
Ponomarev, V. et al. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. Eur. J. Nucl. Med. Mol. Imaging 31, 740–751 (2004).
pubmed: 15014901
Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238–242 (2018).
pubmed: 30046113 pmcid: 6570621

Auteurs

Bernardo Tavora (B)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Tobias Mederer (T)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Kai J Wessel (KJ)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Simon Ruffing (S)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Mahan Sadjadi (M)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Marc Missmahl (M)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Benjamin N Ostendorf (BN)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Xuhang Liu (X)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Ji-Young Kim (JY)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA.

Olav Olsen (O)

Laboratory of Brain Development and Repair, The Rockefeller University, New York, NY, USA.

Alana L Welm (AL)

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Hani Goodarzi (H)

Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, CA, USA.

Sohail F Tavazoie (SF)

Laboratory of Systems Cancer Biology, The Rockefeller University, New York, NY, USA. stavazoie@rockefeller.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH